Found: 2
Select item for more details and to access through your institution.
Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 295, doi. 10.1007/s00280-009-1163-x
- By:
- Publication type:
- Article
Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2015, v. 115, n. 5, p. 744, doi. 10.1111/bju.12845
- By:
- Publication type:
- Article